Senator COLBECK (Tasmania—Minister for Sport and Minister for Senior Australians and Aged Care Services) (14:00): [by video link] I don't have the specific date of when the first order of Moderna was placed, but the Australian government have gone through a process of full recognition and registration of all of the vaccines that we have utilised in the country. We've had the opportunity to take advantage of international experience with respect to the utilisation of the respective vaccines— The PRESIDENT: Senator Gallagher, on a point of order? Senator Gallagher: Mr President, a point of order on direct relevance. We were not asking about the registration, provisional or otherwise, by the TGA. We were asking about the original order of Moderna—the actual vaccine procurement strategy. The PRESIDENT: On the point of order, you reminded the minister of the question. The minister addressed part of the question in his initial response, but you've called for the remaining information to be directly relevant. I believe information about ordering vaccines would, in that case, be directly relevant. He has directly addressed the first point you asked, rather than making a broader comment on vaccine strategy. I've let you remind him of it and I'll listen to his answer carefully. Senator COLBECK: The Moderna vaccine forms a very important part of the overall vaccine strategy for this country. As I said to the chamber a moment ago, I don't have with me the specific date that the first order was placed. I'm happy to take that on notice and confirm that for the chamber. It forms a very important part of the overall vaccine strategy. The way that the government have managed the introduction of new vaccines into the country is to ensure that we've had full data available to the country via the TGA to ensure that the vaccines that we're utilising have high levels of efficacy and are safe. We, through the TGA, took just 23 days to approve the utilisation of the Moderna vaccine. We have used all our resources to ensure that we could have access to this vaccine as quickly as was safely possible so that it could be incorporated into the vaccine rollout program. The PRESIDENT: Senator Gallagher, a supplementary question?